FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved a supplemental application to market a fixed-dose combination of sumatriptan and naproxen sodium for the acute treatment of migraine, developed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• SUMATRIPTAN AND NAPROXEN SODIUM (Sumatriptan and Naproxen Sodium)

Snippet

SUPPL AP for SUMATRIPTAN AND NAPROXEN SODIUM (SUMATRIPTAN AND NAPROXEN SODIUM)